Health insurer
The Food and Drug Administration first announced in 2018 that it was recalling valsartan drugs because of their contamination with likely cancer-causing substances.
It later announced additional recalls of valsartan drugs and similar products manufactured, distributed, or sold by Teva and non-parties, Humana’s Aug. 7 complaint in the U.S. District Court for the District of New Jersey says.
The valsartan drugs are part of ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.